Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mist Health Systems is a clinical-stage biotechnology and medical device company focused on revolutionizing respiratory drug delivery through its proprietary nebulizer technology. The company's platform is designed to deliver high concentrations of therapeutic agents directly to the lungs with superior efficiency and consistency compared to traditional inhalers. By optimizing droplet size and delivery speed, Mist Health Systems aims to improve outcomes for patients with chronic respiratory conditions such as cystic fibrosis, asthma, and COPD. Their business model involves both developing internal therapeutic programs and partnering with pharmaceutical companies to enhance the delivery of existing and novel pulmonary drugs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mist Health Systems.